Welcome to ESGCT
The European Society of Gene and Cell Therapy (ESGCT) promotes basic and clinical research in gene therapy, cell therapy, and genetic vaccines by facilitating education, the exchange of information and technology and by serving as a professional adviser to stakeholder communities and regulatory bodies in Europe.
The ESGCT and BSGT Collaborative Congress 2011 runs from October 27th to 31st in Brighton, UK. The full Congress programme is now available online, as well as the at a glance version. You can also keep up to date with the latest news from in and around the Congress by following @ESGCT on Twitter.
You can listen to the Naked Scientists podcasts from the conference by clicking on the links below:
Day 1, Day 2, Day 3 and the final podcast can be found here
22 December 2011
The field of gene therapy has gained momentum in recent years thanks largely to the clinical successes for the treatment of monogenetic...
ESGCT and SFTCG
Collaborative Congress 2012
26 - 29th October 2012
Versailles, France
26 January 2012
Abstract Submissions and Early Bird Registration Closing Friday 27 January
20 January 2012
This Symposium will explore the recent progress in liver development and stem cell differentiation in the context of cell therapy for...
20 January 2012
The congress is jointly organized by the German Society of Gene Therapy
(DG-GT e.V.), the Foundation of Haemotherapy Research and the...
22 December 2011
The field of gene therapy has gained momentum in recent years thanks largely to the clinical successes for the treatment of monogenetic...
22 December 2011
New Trends in Stem Cell Research & Gene Therapy to Improve Regenerative Medicine, February 20–22, 2012, Jaca, Spain
22 December 2011
organized by the Andalusian Initiative for Advanced Therapies (Andalusian Government) and the University of Granada (Spain) which will...
A Letter from the President
European Society of Gene and Cell Therapy (ESGCT) is one of the leading organizations in the field and is committed to offer continuous support to basic and translational research and clinical applications of gene and cell therapy for inherited and acquired diseases. Many of the recent advances have been made in Europe and ESGCT has played an active role in increasing awareness of gene and cell therapy through...
Seppo Ylä-Herttuala, MD, PhD, FESC
President ESGCT
Read more of the President's letter